A full-circle moment for me: I began my scientific career studying LRRK2 when little was known about its role in Parkinson’s disease pathophysiology, and this work now links it to selective dopamine neuron vulnerability.
A full-circle moment for me: I began my scientific career studying LRRK2 when little was known about its role in Parkinson’s disease pathophysiology, and this work now links it to selective dopamine neuron vulnerability.